Alternatives
Alternatives to Gadavist 39306.8 mg/65 mL injection
1 other presentations of Gadobutrol 39306.8 mg/65 mL injection
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Gadobutrol), strength (39306.8 mg/65 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Gadavist 39306.8 mg/65 mL injectionThis pageIntravenous | Bayer HealthCare Pharmaceuticals | US FDA | 10 bottles of 65 mL, 65 mL | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). If solidification occurs due to cold exposure, bring GADAVIST to room temperature before use and inspect to ensure that the solution is clear and colorless to pale yellow. | On request | — | Available on request |
| Gadobutrol 39306.8 mg/65 mL injectionIntravenous | — | US FDA | 1 vial of 65 mL, 1 vial of 65 mL | Should freezing occur, gadobutrol injection should be brought to room temperature before use. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). If allowed to stand at room temperature, gadobutrol injection should return to a clear and colorless to pale yellow solution. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Gadavist 39306.8 mg/65 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.